breast cancer
Conditions
Interventions
Experimental group1(SNVP group):SNVP + traditional prophylactic treatment group
Experimental group2 (MNVP group):traditional prophylactic treatmentgroup
Experimental group3 (SNVP group):combined prophylactic treatment
Experimental group4 (MNVP group):combined prophylactic treatment
Sponsors
Chinese Academy of Medical Sciences Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients who have given birth to at least one child in a full-term pregnancy; 2. Aged 18 to 60 years; 3. Histologically or cytologically confirmed breast adenocarcinoma; 4. American society of anesthesiologists (American society of anesthesiologists, ASA) grade I or II.
Exclusion criteria
Exclusion criteria: 1. Suffering from Meniere motion sickness; 2. Diabetic patients; 3. Have used antiemetic drugs within 24 hours or received surgical treatment within 30 days; 4. Pregnant or lactating women; 5. Long-term drinking, long-term use of psychotropic drugs such as sedatives or antidepressants; 6. Patients with digestive system diseases such as gastric ulcer or liver and kidney diseases; 7. Allergy to anesthetics; 8. Preoperative radiotherapy or chemotherapy; 9. Unable to cooperate with the research for any reason, such as the following: language comprehension difficulties, mental illness, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| growth differentiation factor-15; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting; | — |
Countries
China
Contacts
Public ContactWang Baona
Chinese Academy of Medical Sciences Cancer Hospital
Outcome results
None listed